Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PNST
3926
DELISTED
Pinstripes Holdings, Inc.
PNST
| $185K | ﹤0.01% |
240,931
-12,461
| -5% | -$23.6K |
|
3927
Xos
XOS
$37.7M
| $184K | ﹤0.01% |
40,438
+4,510
| +13% | +$24.9K |
|
3928
Oculis Holding
OCS
$704M
| $183K | ﹤0.01% |
14,944
| – | – |
|
3929
Quantum Corp
QMCO
$474M
| $183K | ﹤0.01% |
52,137
+1,218
| +2% | +$6.87K |
|
3930
SAB Biotherapeutics
SABS
$355M
| $182K | ﹤0.01% |
67,542
+8,127
| +14% | +$22.5K |
|
3931
BioXcel Therapeutics
BTAI
$27.8M
| $182K | ﹤0.01% |
18,628
+1,958
| +12% | +$26.3K |
|
3932
AiRWA Inc
YYAI
$82.2K
| $182K | ﹤0.01% |
+10
| New | +$210K |
|
3933
US GoldMining
USGO
$120M
| $182K | ﹤0.01% |
22,529
+2,126
| +10% | +$12.1K |
|
3934
enGene Therapeutics
ENGN
$121M
| $182K | ﹤0.01% |
27,516
| – | – |
|
3935
bioAffinity Technologies
BIAF
$3.2M
| $181K | ﹤0.01% |
2,906
+586
| +25% | +$35.1K |
|
3936
TherapeuticsMD
TXMD
$24M
| $180K | ﹤0.01% |
108,333
+12,856
| +13% | +$22.4K |
|
3937
Urban One Class D
UONEK
$23.8M
| $180K | ﹤0.01% |
16,194
-2,095
| -11% | -$27.8K |
|
|
VINC
3938
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $180K | ﹤0.01% |
12,540
+1,001
| +9% | +$13.7K |
|
|
ABVX
3939
Abivax
ABVX
$11.4B
| $179K | ﹤0.01% |
15,572
+1,183
| +8% | +$14.2K |
|
|
TTOO
3940
DELISTED
T2 Biosystems, Inc
TTOO
| $179K | ﹤0.01% |
90,880
-39,509
| -30% | -$150K |
|
3941
Beasley Broadcasting Group
BBGI
$40M
| $177K | ﹤0.01% |
16,493
-2,226
| -12% | -$27K |
|
3942
LGL Group
LGL
$46.5M
| $176K | ﹤0.01% |
28,717
+2,597
| +10% | +$14.8K |
|
3943
Clean Energy Technologies
CETY
$10.7M
| $176K | ﹤0.01% |
11,712
+1,922
| +20% | +$31.9K |
|
3944
Odyssey Marine Exploration
OMEX
$51.8M
| $175K | ﹤0.01% |
211,496
+2,269
| +1% | +$8.51K |
|
|
NEUE
3945
DELISTED
NeueHealth
NEUE
| $175K | ﹤0.01% |
33,447
+971
| +3% | +$5.14K |
|
|
AIFF
3946
Firefly Neuroscience
AIFF
$18.7M
| $174K | ﹤0.01% |
57,358
+53,472
| +1,376% | +$280K |
|
3947
Lucid Diagnostics
LUCD
$184M
| $174K | ﹤0.01% |
213,540
+9,185
| +4% | +$7.52K |
|
|
DALN
3948
DELISTED
DallasNews
DALN
| $173K | ﹤0.01% |
41,370
-14,183
| -26% | -$56.9K |
|
3949
AudioCodes
AUDC
$253M
| $173K | ﹤0.01% |
17,801
| – | – |
|
|
KORE
3950
DELISTED
KORE Group Holdings
KORE
| $173K | ﹤0.01% |
76,480
-4,515
| -6% | -$10.6K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.